QIAGEN PE Ratio 2006-2021 | QGEN

Current and historical p/e ratio for QIAGEN (QGEN) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. QIAGEN PE ratio as of December 06, 2021 is 20.61.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

QIAGEN PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-12-06 53.38 20.85
2021-09-30 51.68 $2.56 20.19
2021-06-30 48.38 $2.06 23.49
2021-03-31 48.69 $1.92 25.36
2020-12-31 52.85 $1.53 34.54
2020-09-30 52.26 $0.81 64.52
2020-06-30 42.81 $0.03 1427.00
2020-03-31 41.60 $-0.16 0.00
2019-12-31 33.80 $-0.20 0.00
2019-09-30 32.97 $-0.13 0.00
2019-06-30 40.55 $0.84 48.27
2019-03-31 40.68 $0.81 50.22
2018-12-31 34.45 $0.82 42.01
2018-09-30 37.88 $0.38 99.68
2018-06-30 36.16 $0.33 109.58
2018-03-31 32.31 $0.23 140.48
2017-12-31 30.93 $0.17 181.94
2017-09-30 31.50 $0.39 80.77
2017-06-30 33.53 $0.33 103.04
2017-03-31 28.97 $0.36 80.72
2016-12-31 29.10 $0.34 85.28
2016-09-30 28.50 $0.51 55.99
2016-06-30 22.65 $0.51 44.51
2016-03-31 23.20 $0.53 43.81
2015-12-31 28.71 $0.55 52.17
2015-09-30 26.81 $0.46 58.68
2015-06-30 25.74 $0.46 56.34
2015-03-31 26.17 $0.49 53.61
2014-12-31 24.36 $0.51 47.88
2014-09-30 23.65 $0.65 36.14
2014-06-30 25.39 $0.69 37.05
2014-03-31 21.90 $0.31 70.33
2013-12-31 24.73 $0.29 85.06
2013-09-30 22.22 $0.20 112.64
2013-06-30 20.68 $0.15 142.20
2013-03-31 21.89 $0.52 42.15
2012-12-31 18.85 $0.56 33.61
2012-09-30 19.22 $0.39 48.71
2012-06-30 17.34 $0.43 40.73
2012-03-31 16.17 $0.43 37.97
2011-12-31 14.34 $0.43 33.68
2011-09-30 14.36 $0.58 24.69
2011-06-30 19.75 $0.58 33.96
2011-03-31 20.82 $0.60 34.56
2010-12-31 20.30 $0.62 32.58
2010-09-30 18.42 $0.65 28.16
2010-06-30 19.96 $0.69 29.12
2010-03-31 23.87 $0.68 35.37
2009-12-31 23.19 $0.65 35.45
2009-09-30 22.10 $0.59 37.33
2009-06-30 19.31 $0.51 37.94
2009-03-31 16.57 $0.47 35.47
2008-12-31 18.24 $0.45 40.85
2008-09-30 20.49 $0.39 51.94
2008-06-30 20.90 $0.25 83.89
2008-03-31 21.60 $0.28 77.03
2007-12-31 21.86 $0.31 70.15
2007-09-30 20.16 $0.37 53.91
2007-06-30 18.47 $0.55 33.57
2007-03-31 17.84 $0.50 35.79
2006-12-31 15.71 $0.49 32.19
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.170B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $126.142B 7.97
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
Biohaven Pharmaceutical Holding (BHVN) United States $6.566B 0.00
Arcus Biosciences (RCUS) United States $3.079B 0.00
Emergent Biosolutions (EBS) United States $2.259B 8.12
Myovant Sciences (MYOV) United Kingdom $1.408B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.382B 0.00
Zymeworks (ZYME) Canada $0.848B 0.00
SQZ Biotechnologies (SQZ) United States $0.318B 0.00
Ambrx Biopharma (AMAM) United States $0.306B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90